Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 18, 2003
A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients
Jerry O Stern, Patrick A Robinson, James Love, et al.
Contemporary Clinical Trials Communications
|
April 17, 2025
Standardization of laparoscopic intraperitoneal onlay mesh repair for incisional hernia: Impact on clinical outcome and quality-of-life (LIPOM trial, NCT 02089958)
A Hellinger, F Wotzlaw, V Fackeldey, et al.
Toxicologic Pathology
|
March 29, 2011
A twenty-eight-day mechanistic time course study in the rhesus monkey with hepatitis C virus protease inhibitor BILN 2061
James H Stoltz, Jerry O Stern, Qihong Huang, et al.
Antimicrobial Agents and Chemotherapy
|
July 22, 2015
Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies
K L Berger, J Scherer, M Ranga, et al.
Science (New York, N.Y.)
|
February 13, 2001
Coupling and entangling of quantum states in quantum dot molecules
M Bayer, P Hawrylak, K Hinzer, et al.
Physical Review Letters
|
December 18, 2002
From quantum Hall ferromagnetism to huge longitudinal resistance at the 2/3 fractional quantum Hall state
S Kraus, O Stern, J G S Lok, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1975
Studies on the spin state of 3-methylcholanthrene induced cytochrome P-450 from rat liver
J O Stern, E Peisach, J Peisach, et al.
BMC Infectious Diseases
|
December 17, 2009
Hepatic profile analyses of tipranavir in Phase II and III clinical trials
Jaromir Mikl, Mark S Sulkowski, Yves Benhamou, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 7, 2016
Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection
Shuhei Nishiguchi, Yasuhisa Urano, Keiko Suzaki, et al.
Plos One
|
December 29, 2016
HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment
Christoph Sarrazin, Michael Manns, Jose Luis Calleja, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 18, 2003
A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients
Jerry O Stern, Patrick A Robinson, James Love, et al.
Contemporary Clinical Trials Communications
|
April 17, 2025
Standardization of laparoscopic intraperitoneal onlay mesh repair for incisional hernia: Impact on clinical outcome and quality-of-life (LIPOM trial, NCT 02089958)
A Hellinger, F Wotzlaw, V Fackeldey, et al.
Toxicologic Pathology
|
March 29, 2011
A twenty-eight-day mechanistic time course study in the rhesus monkey with hepatitis C virus protease inhibitor BILN 2061
James H Stoltz, Jerry O Stern, Qihong Huang, et al.
Antimicrobial Agents and Chemotherapy
|
July 22, 2015
Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies
K L Berger, J Scherer, M Ranga, et al.
Science (New York, N.Y.)
|
February 13, 2001
Coupling and entangling of quantum states in quantum dot molecules
M Bayer, P Hawrylak, K Hinzer, et al.
Physical Review Letters
|
December 18, 2002
From quantum Hall ferromagnetism to huge longitudinal resistance at the 2/3 fractional quantum Hall state
S Kraus, O Stern, J G S Lok, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1975
Studies on the spin state of 3-methylcholanthrene induced cytochrome P-450 from rat liver
J O Stern, E Peisach, J Peisach, et al.
BMC Infectious Diseases
|
December 17, 2009
Hepatic profile analyses of tipranavir in Phase II and III clinical trials
Jaromir Mikl, Mark S Sulkowski, Yves Benhamou, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 7, 2016
Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection
Shuhei Nishiguchi, Yasuhisa Urano, Keiko Suzaki, et al.
Plos One
|
December 29, 2016
HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment
Christoph Sarrazin, Michael Manns, Jose Luis Calleja, et al.
Page
of 8